scispace - formally typeset
E

Emilie Barrandon

Researcher at University of Paris

Publications -  10
Citations -  544

Emilie Barrandon is an academic researcher from University of Paris. The author has contributed to research in topics: Cancer & Cancer prevention. The author has an hindex of 5, co-authored 10 publications receiving 479 citations. Previous affiliations of Emilie Barrandon include Sorbonne.

Papers
More filters
Journal ArticleDOI

Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials

TL;DR: The evidence that nutritional prevention of cancer through beta‐carotene supplementation should not be recommended is added, as it was associated with increased risk not only of lung cancer but also of gastric cancer at doses of 20–30 mg day−1, in smokers and asbestos workers.
Journal ArticleDOI

Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies.

TL;DR: Obesity was associated to significantly increased risks of contralateral breast, breast, and colorectal second primary cancers in women with breast cancer, and this result emphasizes the importance of prevention policies aiming to reduce overweight and obesity prevalence.
Journal ArticleDOI

Maternal Alcohol Consumption during Pregnancy and Risk of Childhood Leukemia: Systematic Review and Meta-analysis

TL;DR: Maternal alcohol consumption during pregnancy is associated with a significantly increased risk of AML in young children, and avoidance of maternal alcohol drinking during pregnancy might contribute to a decrease in the risk of childhood AML.
Journal ArticleDOI

Mode de vie et cancer du sein: quels conseils pour la prise en charge de l'après cancer ?

TL;DR: Physical activity, when practiced regularly, improves asthenia, quality of life and even survival, without any detrimental effect, but should however be initiated after an evaluation of patient’s ability and comorbidities, and be realized in specific centers with careful medical follow-up.